{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}

Risk Profile Improvements

  • Material Weakness (improved) — Material weaknesses in internal controls over financial reporting identified as of December 31, 2024 and unremediated through March 31, 2025 have now been resolved; controls deemed effective as of March 31, 2026.
NASDAQ: TRAW Traws Pharma, Inc. 10-Q

Traws remedies control weaknesses, raises $10M as FDA halts lead drug; cash at $3.1M

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TRAW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov

Generated by AI · May 29, 2026 12:40 AM